Cargando…

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products

Detalles Bibliográficos
Autores principales:	Romero, Carolina, Díez, José María, Gajardo, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906732/ https://www.ncbi.nlm.nih.gov/pubmed/33606999 http://dx.doi.org/10.1016/S1473-3099(21)00059-1

Ejemplares similares

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants
por: Romero, Carolina, et al.
Publicado: (2023)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Why the application of IVIG might be beneficial in patients with COVID-19
por: Kindgen-Milles, Detlef, et al.
Publicado: (2022)

Challenges and issues of SARS-CoV-2 pool testing
por: Lee, Jaehyeon, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Mishra, Baijayantimala, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing
por: Eberhardt, Jens N, et al.
Publicado: (2020)

Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
por: Bekele, Bisrat, et al.
Publicado: (2023)

Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies
por: Ulisses, Luiz Roberto de Sousa, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
por: Lohse, Stefan, et al.
Publicado: (2020)

Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products
por: Díez, José María, et al.
Publicado: (2022)

Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply
por: Mazeraud, Aurélien, et al.
Publicado: (2022)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Pooled saliva samples as an approach to reduce the spread of infections with SARS-CoV-2
por: Möst, Johannes, et al.
Publicado: (2021)

Evaluation of SARS CoV-2 RT-PCR in a multiple sample pool
por: Garg, Jaya, et al.
Publicado: (2021)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements
por: Benites, Bruno Deltreggia, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
por: Rojas-Jiménez, Gabriel, et al.
Publicado: (2022)

Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives
por: Sun, Pan, et al.
Publicado: (2023)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor
por: Busca, Alessandro, et al.
Publicado: (2022)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling
por: Anurathapan, Usanarat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9t6to184410h8fum000gk5mkrb